head and neck squamous cell carcinomas
Showing 1 - 4 of 4
Head and Neck Squamous Cell Carcinomas Trial (Tislelizumab + Dasatinib + Quercetin, surgery)
Not yet recruiting
- Head and Neck Squamous Cell Carcinomas
- Tislelizumab + Dasatinib + Quercetin
- surgery
- (no location specified)
Feb 2, 2023
Advanced Solid Tumors, Gastric Cancer, Gastroesophageal Junction Cancer Trial in Japan, United States (PF-07265028, Sasanlimab)
Recruiting
- Advanced Solid Tumors
- +5 more
- PF-07265028
- Sasanlimab
-
Scottsdale, Arizona
- +7 more
Jan 23, 2023
Head and Neck Squamous Cell Carcinomas Trial in Guanzhou (drug, procedure, radiation)
Recruiting
- Head and Neck Squamous Cell Carcinomas
- Tislelizumab（neoadjuvant）
- +6 more
-
Guanzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Oct 28, 2022
Head and Neck Squamous Cell Carcinomas Trial in Guangzhou (Consolidation Toripalimab)
Recruiting
- Head and Neck Squamous Cell Carcinomas
- Consolidation Toripalimab
-
Guangzhou, Guangdong, China
- +1 more
Oct 2, 2021